The epithelial sodium channel (ENaC) mediates the first step in Na 1 reabsorption in epithelial cells such as kidney, colon, and airways and may consist of four homologous subunits (a, b, g, d). Predominantly, the a-subunit is expressed in these epithelia, and it usually forms functional channels with the b-and g-subunits. The d-subunit was first found in human brain and kidney, but the expression was also detected in human cell lines of lung, pancreatic, and colonic origin. When co-expressed with b and g accessory subunits in heterologous systems, the two known isoforms of the d-ENaC subunit (d1 and d2) can build amiloride-sensitive Na 1 channels. In the present study we demonstrate the expression and function of the d-subunit in human nasal epithelium (HNE). We cloned and sequenced the full-length cDNA of the d-ENaC subunit and were able to show that in nasal tissue at least isoform 1 is expressed. Furthermore, we performed Western blot analyses and compared the cell surface expression of the d-subunit with the classically expressed a-subunit by using immunofluorescence experiments. Thereby, we could show that the quantity of both subunits is almost similar. In addition, we show the functional expression of the d-ENaC subunit with measurements in modified Ussing chambers, and demonstrate that in HNE a large portion of the Na 1 transport is mediated by the d-ENaC subunit. Therefore, we suppose that the d-subunit may possess an important regulatory function and might interact with other ENaC subunits or members of the DEG/ENaC family in the human respiratory epithelium.
Members of the degenerin/epithelial Na 1 channel (DEG/ ENaC) family of non-voltage-gated ion channels are expressed in a huge variety of epithelia and neuronal tissues. The immense functional diversity includes acid sensing, mechanotransduction, and peptide gating mediated by degenerins and acid-sensitive ion channels (ASICs) as well as Na 1 absorption by the amiloride-sensitive epithelial sodium channel ENaC (1, 2) .
Four homologous ENaC subunits named a, b, g, and d have been identified, which share sequence homology of approximately 37% at the amino acid level (3) (4) (5) . The correlation between these subunits and the exact stoichiometry of the channel is still a matter of discussion. Over a long period it was proposed that ENaC is a tetramer (6, 7) , while others suggested that ENaC is formed by nine subunits (8, 9) . Since Jasti and colleagues determined the crystal structure of chicken ASIC1 (10) , ENaC was mapped to these structural coordinates and therefore, a trimeric structure was postulated (11) .
Predominantly, the a-subunit is expressed in epithelia such as kidney, lung, and colon, and there it usually forms functional channels with the b-and g-subunits (3). It is involved in the control of Na 1 balance, blood volume, and pressure. Beside the a-ENaC the d-subunit is characterized as a pore-forming subunit that, when expressed together with b and g, produces amiloridesensitive Na 1 currents that are quite different than those that are generated by the classical ENaC channel composition. It was reported that d-ENaC generates a constitutive current that is two orders of magnitude larger when associated with b-and g-subunits than that of homomeric d-ENaC channels (5) . While co-expression of a-with g-ENaC increases the current by one order of magnitude (3, 12) , it could be demonstrated that none of the a-, b-, or g-subunits alone altered or increased the d-ENaC current when co-expressed with this subunit (5) . These experiments were performed in the Xenopus laevis oocyte expression system that allows characterizing functional properties of the particular subunit under defined conditions.
Up to now it is not known whether the d-ENaC subunit associates with other subunits in vivo to play a role in physiologic functions. However, the d-subunit has a widespread distribution in different tissues (5, (13) (14) (15) and therefore is often co-expressed with the other ENaC subunits and/or ASICs (16, 17) . When expressed in human brain, it was shown that d-ENaC and its isoform (d2) can be activated by protons, indicating that they may contribute to pH sensitivity in this tissue (13, 18) . New data show that d-ENaC is also a candidate molecule for pH sensing in the gastrointestinal system in humans (19) as well as in human skin (15) .
In general, it is known that changes in the stoichiometry of heteromultimeric proteins (e.g., ENaC) lead to different functional properties (20) . Since ENaC and ASIC subunits are co-expressed in multiple tissues and cell types, it could be demonstrated that combinations of ASIC1 with ENaC subunits exhibit novel electrophysiologic properties (17) . It was shown that ion channel properties, including cation selectivity and pharmacologic inhibition, are affected by the subunit composition of the expressed channel.
These observations prompted us to investigate whether the d-subunit is expressed in human respiratory epithelium and whether this subunit is also functionally active. Previously, we have already demonstrated the expression of a-, b-, and g-ENaC in human nasal epithelium (HNE) (21) . Since cells derived from HNE have been reliable and useful tools for the study of ion transport in the respiratory tract (22, 23) , we used that technique to study the expression and function of d-ENaC.
First of all we investigated the expression of the d-subunit in HNE. Thereby, we (1) detected the d-subunit via RT-PCR and (2) showed its presence in Western blot experiments. In addition, we (3) compared the cell surface expression of the d-subunit with the classically expressed a-subunit by using immunofluorescence experiments, and showed that the quantity of both subunits is almost similar. Thereafter, we were interested in the portion of the d-ENaC-mediated Na 1 current, which (4) could be distinguished from the amiloride-sensitive current by the specific blocker Evans Blue. It was shown that the application of Evans Blue inhibits the activity of d-ENaC while the a-subunit was not affected (24) . Therefore, Evans Blue seems to be a d-subunitspecific inhibitor and allows distinguishing between the functional activity of the a-and d-subunits, respectively. Our data represent the first functional characterization of the ENaC d-subunit in HNE.
MATERIALS AND METHODS

Patients
We obtained nasal specimens from patients undergoing nasal surgery. The samples were nasal polyps or turbinates of patients suffering from chronic sinusitis. The study was approved by the committees for human studies of the University of Muenster (Ethik Kommission Muenster) and the University of Giessen (Ethik Kommission der Justus-LiebigUniversitaet Giessen). All patients gave informed consent.
Extraction of RNA
Total RNA was extracted from primary cultured human nasal cells following the standard protocol of RNeasy Mini Kit plus (Qiagen, Hilden, Germany). The concentration of RNA was determined by absorbance measurement at 260 nm (A 260 ) in a spectrophotometer using ultraviolet cuvettes. The integrity and size distribution of total RNA was analyzed via denaturing agarose gel electrophoresis and ethidium bromide staining.
cDNA Synthesis
Total RNA (1 mg) was used to generate first-strand cDNA by using the SuperScript II reverse transcriptase kit (Invitrogen, Karlsruhe, Germany) and oligo (dT) primers.
Molecular Cloning of d-ENaC cDNA
After PCR amplification with specific oligonucleotide primers according to the published sequences of human ENaC (http://www.ncbi.nih. gov), all expected distinct bands were excised using the QIAquick Gel Extraction Kit (Qiagen) and cloned into the pSC-A vector (StrataClone PCR Cloning Kit; Stratagene, Heidelberg, Germany). The nucleotide sequence of d-ENaC cDNA was submitted to GenBank (accession number EU489064).
Sequence Data Analysis
For cDNA sequence analysis we used the tools provided by the ExPasy Molecular Biology Server of the Swiss Institute of Bioinformatics (http:// www.expasy.ch) and the National Centre for Biotechnology Information (http://www.ncbi.nlm.nih.gov). All clones were commercially sequenced by GENterprise (GENterprise GmbH, Mainz, Germany).
Cell Culture
Primary cell culture of the HNE was performed as described before (25) . The nasal epithelial cells were isolated by enzymatic digestion for 24 to 48 hours and afterward seeded on permeable collagen filters with a diameter of 14 mm (Cellagen TM dics CD 24; MP Biomedicals, Heidelberg, Germany). The cells were cultured with serum-free F-12 Nutrient Mixture (Ham) (Invitrogen) supplemented with the following agents: insulin (2 mg/ml) (Invitrogen), epidermal growth factor (13 ng/ml) (Sigma, Deisenhofen, Germany), endothelial cell growth supplement (7.5 mg/ml) (Becton Dickinson GmbH, Heidelberg, Germany), triiodo-thyronine (3 nM) (Sigma), hydrocortisone (100 nM) (Sigma), gentamycin (10 mg/ml) (Biochrom AG, Berlin, Germany), penicillin/ streptomycin (100 U/ml) (Invitrogen), L-Glutamin (2 mM) (Invitrogen), and transferrin (4 mg/ml) (Invitrogen). Previously, it was shown that these supplements had no effect on the electrical parameters of the HNE (25) . Cells were incubated in 95% air and 5% CO 2 at 378C. Seven to nine days after seeding the cells on the membrane, we normally obtained confluent monolayers and proceeded with Ussing chamber measurements.
For immunofluorescence experiments cells were grown in culture dishes (Ø 5 3.5 cm) coated with collagen (0.15 mg/ml, Collagen Typ I; Sigma). After reaching confluence, cells were split using trypsin (0.05%) and then cultured on 8-well diagnostic microscope slides (Menzel GmbH, Braunschweig, Germany), also coated with collagen. These slides were placed in Petri dishes filled with culture medium. For immunofluorescence experiments the cells were fixed in glutaraldehyde at 378C. Briefly, glutaraldehyde was added to a final concentration of 0.05% to the cell culture medium. After a period of 15 minutes the fixative was removed and cells were stored at 48C.
Protein Biochemistry
Membrane proteins from primary cultured HNE cells were isolated using lysis buffer (1 mM Tris, 15 mM NaCl, 0.2 mM EDTA, 2% Triton X-100), and a protease inhibitor cocktail (Sigma) was added to this detergent mixture. It was shown that 2% Triton-X 100 is sufficient to solve all of the intracellular and cell surface pools of the sodium channel ENaC (26) . The extracts were homogenized with a Sonifier ultrasonic cell disrupter (Branson, Danbury, CT) and centrifuged for 30 minutes at 3,220 3 g at 48C to remove insoluble material. The concentration of the proteins in the supernatant was measured photometrically using the BCA test (Pierce, Rockford, IL). For the detection of the a-and d-ENaC subunits, 30 mg of total membrane proteins were separated via SDS-PAGE (7.5% acrylamide) and transferred to a PVDF membrane. Nonspecific binding sites were blocked for 2 hours with 5% nonfat dry milk in Tris-buffered saline/Tween (TBST: 10 mM Tris HCl, pH 7.4; 140 mM NaCl; 0.3% Tween 20). The d-ENaC subunit was detected with a rabbit anti d-ENaC antibody (Santa Cruz Biotechnology, Santa Cruz, CA) with a concentration of 1:200 diluted in 5% nonfat dry milk/TBST overnight at 48C. The ENaC a-subunit was detected with a rabbit antia-ENaC antibody (PA1-920A; Dianova, Hamburg, Germany) with a concentration of 1:250 diluted in 5% nonfat dry milk/TBST at 48C overnight. After washing in TBST, the membrane was incubated for 1 hour at room temperature with the goat anti-rabbit IgGs conjugated with alkaline phosphatase (Santa Cruz) diluted 1:10,000 in 5% nonfat dry milk/TBST. The membrane was washed again in TBST, and detection was performed with NBT (nitroblue tetrazolium) and BCIP (5-bromo-4-chloro-3-indolyl phosphate).
As positive control we used MIA Paca-2 cell lysate (Santa Cruz) to verify the specificity of the anti d-ENaC antibody and a neutralizing peptide (PEP-088; Dianova) to confirm the a-ENaC antibody specificity.
Antibody Staining
Antibody staining was performed as described previously (27) . Briefly, human nasal cells were gently washed five times in phosphate-buffered saline (PBS, in mM: 140 NaCl, 2 KCl, 4 Na 2 HPO 4 , 1 KH 2 PO 4 , pH 7.4) at room temperature after fixation (0.05% glutaraldehyde) and incubated afterwards for 30 minutes in 100 mM glycine/PBS solution. The cells were washed again five times by gentle shaking in PBS and then blocked with 10% normal goat serum (NGS) at room temperature for 1 hour. For the immunofluorescence experiments we used antibodies that bind to the extracellular loop of the ENaC subunits, respectively. The primary polyclonal rabbit anti a-ENaC (Santa Cruz) and anti d-ENaC (Santa Cruz) antibodies were diluted 1:1,000 and 1:200, respectively, in 10% NGS and applied to the cells.
After 1 hour of incubation with the primary antibody the cells were washed five times in PBS. For Quantum Dot (QD)-labeling we incubated the cells with QD655 goat F(ab9) 2 anti-rabbit IgG conjugates (1:100; Invitrogen) at room temperature in the dark for 1 hour. Cells were then washed again five times in PBS, two times in HEPES (in mM: 140 NaCl, 5 KCl, 1 MgCl 2 , 1 CaCl 2 , 5 glucose, 10 HEPES), and fixed with 0.05% glutaraldehyde in HEPES buffer for 15 minutes.
As a negative control, we incubated human nasal epithelial cells only with the secondary antibody (see Figure E1A in the online supplement). The background staining of the cells is due to fixation with glutaraldehyde, which allows the identification of cell borders.
For further control experiments, we incubated human nasal cells with a primary anti-Tubulin antibody (1:200) (Tubulin, a, DLN-09993; Dianova) and Cy3-labeled anti-mouse secondary antibody (1:500; Dianova) to ensure that the cells are not permeabilized during preparation ( Figure E1B) . For comparison only, we detected a-Tubulin in the cells by permeabilization with paraformaldehyde (0.37%) ( Figure E1C ). The staining with the anti-Tubulin antibody of nonpermeabilized HNE cells was checked in every experiment with an inverted fluorescence microscope.
Image Analysis
Immunofluorescence images were acquired with an inverted fluorescence microscope (Axiovert 200; Zeiss, Jena, Germany) equipped with a 100 3 1.45 oil immersion objective. We used the following filter: QD655, 420 nm excitation, 655 nm emission (XF302-1 filter; Omega Optical, Brattleboro, VT). Cell surface areas of HNE were selected manually, and QD-labeled ENaC molecules in the plasma membrane of the cells were detected by focusing on the upper surface of the cells. Data acquisition and analysis were performed with the Metavue Software (Visitron, Puchheim, Germany). Therefore, numbers of QD-labeled a-and d-ENaC molecules at the cell surface were counted manually. Subsequently, means were corrected with the negative control values (HNE cells incubated only with the secondary antibody).
Transepithelial Measurements
After reaching confluence, the nasal epithelial cells were mounted in modified Ussing chambers designed by Prof. Willy Van Driessche (KU Leuven, Belgium). The electrical measurements were performed as described in more detail elsewhere (28) . Briefly, the two compartments of the Ussing chamber were continuously perfused with cell culture Ringer at 378C. For voltage current-measurements we used KCl electrodes, which were connected to Ringer solution through agar bridges. For the measurements the transepithelial potential (V t ) was clamped to 0 mV with a low noise voltage clamp. The short-circuit current (I sc ) was continuously monitored using the computer program ImpDsp1.4 (Prof. Willy Van Driessche, KU Leuven, Belgium). The measured area had a size of 0.5 cm 2 , while the electrical parameters were normalized to an area of 1 cm 2 .
siRNA Transfection Procedures
To down-regulate d-ENaC, HNE cells were transfected with 10 nM siRNA using HiPerfect Transfection reagent (Qiagen). Seven days after seeding the cells on the membrane, we normally obtained confluent monolayers and performed the transfection procedure following the manufacturer's protocol. The HiPerfect/siRNA complex remained on the apical side of the support for 24 hours and the functional properties were measured in Ussing chamber experiments.
We determined transfection efficiency by semiquantitative RT-PCR. We used commercially available siRNA complementary to the d-ENaC subunit (Hs_SCNN1D_2 HP siRNA; Qiagen).
Semiquantitative RT-PCR
Two microliters of cDNA first-strand products were amplified with 1.25 units TopTaq polymerase (Qiagen) in the presence of the specific primers, respectively (d-ENaC sense: 59-CAG CAT CCG AGA GGA CGA GGT G-39, d-ENaC antisense: 59-CGG TAG TTG AGC TCC TGG TAG ACG-39). The oligonucleotide primers for RT-PCR were selected to bind specifically to human cDNA and created spanning Exon/Exon boundaries to prevent amplification of genomic DNA. As external control we used human glycerin-aldehyde-3-phosphatedehydrogenase (GAP-DH)-specific primers (GAP-DH sense: 59-GAC ATC AAG AAG GTG GTG AAG CAG-39, GAP-DH antisense: 59-GCC ATG AGG TCC ACC ACC CTG-39), which produce a PCR fragment of 218 bp. The conditions were chosen that none of the cDNAs analyzed reached a plateau but are situated in the exponential phase of the amplification. A first cycle of 3 minutes at 948C, 45 seconds at 598C, and 1 minute at 728C was followed by 45 seconds at 948C for 32 cycles.
siRNA Control Experiments
For control experiments we used the AllStars Negative Control siRNA (Qiagen), which is a scrambled, nonsilencing siRNA with no homology to any known mammalian gene. Furthermore, the gene expression analyses were performed on cells that have not been treated (nontransfected control).
Semiquantitative Analyses
Images of the RT-PCR loaded on ethidium bromide-stained agarose gels were recorded with a digital camera (Canon, Krefeld, Germany) combined with the BioDocAnalyze system (Biometra, Gö ttingen, Germany) and quantification was performed by densitometry using ImageJ analysis software 1.36 (NIH, Bethesda, MD; http://rsb.info.nih. gov/ij/). The ratio between the sample RNA and GAP-DH was calculated to normalize the initial variations in sample concentration and as control for reaction efficiency.
Solutions
Cell culture Ringer was composed as follows (in mM): 130 NaCl, 5 KCl, 1 CaCl 2 , 2 MgCl 2 , 5 glucose, 10 HEPES. In the Na 1 -free solution used, NaCl was replaced by an equivalent amount of TMACl (tetramethylammonium chloride). For investigation of the amiloridesensitive a-and d-ENaC currents, the apical compartment of the Ussing chamber was perfused with amiloride (100 mM) and Evans Blue (300 mM) in cell culture Ringer, respectively.
Statistics
Where applicable, data are expressed as arithmetic means 6 SEM; n is the number of experiments. Statistical analysis was made by the t test where appropriate, and a significant difference was assumed at P , 0.05, P , 0.01 (* or **, respectively, in the relevant figures).
RESULTS
Molecular Cloning of d-ENaC from HNE
The d-ENaC subunit was cloned and sequenced and the amino acid sequence was compared in a multi-sequence alignment with the previously published sequences of d-ENaC (http://www.ncbi. nlm.nih.gov). Using RT-PCR we showed that the transcript and protein encoding d-ENaC (isoform 1) is expressed in HNE. The coding region of the d-ENaC subunit comprises 1,917 bp translated into 638 amino acids. The nucleotide sequence of d-ENaC cDNA was submitted to GenBank (accession number: EU489064).
Semiquantitative RT-PCR of d-ENaC Expression in HNE
For subsequent investigations it was necessary to down-regulate d-ENaC expression. Therefore, we used specific siRNA directed against d-ENaC and performed semiquantitative RT-PCR to confirm the knockdown. The d-ENaC-specific primer produced a fragment of 474 bp. For normalization we used human GAP-DH specific primers (239 bp fragment). We observed that the expression of the d-subunit is reduced (47.2 6 3.19%) by approximately 52.8% by specific siRNA compared with the nontransfected cell control (n 5 7) ( Figure 1A) . The nonsilencing, scrambled siRNA that we used as negative control (NC) caused no considerable changes in d-ENaC expression (98.14 6 13.5%) ( Figure 1B) . Representative images of the semiquantitative RT-PCR are shown in Figure 1C .
Detection of the d-ENaC Protein
For the determination of the presence and abundance of d-ENaC in HNE on the protein level, we performed Western blot analyses. These experiments were repeated three times and a representative experiment is shown (Figure 2 ). According to the manufacturer's specifications the anti-d-ENaC antibody detected one distinct and specific band in the range of 100 kD, representing the d-ENaC subunit in HNE. Furthermore, we demonstrated the knockdown of the d-subunit with siRNA. We detected a specific band of d-ENaC in nontransfected HNE cells (Figure 2, lane 1) and a decreased band in the siRNAtransfected sample (Figure 2, lane 2) . As positive control we used MIA PaCa-2 cell lysate (Santa Cruz) (Figure 2, lane 3) .
To demonstrate that the expression of a-ENaC is unaffected by the transfection of the d-ENaC siRNA, we identified the a-subunit in the range of 65 kD in nontransfected ( Figure E2 , lane 1) and in d-ENaC siRNA transfected HNE cells ( Figure  E2, lane 2) . As reviewed by Rossier and Stutts, this 65-kD band represents an endogenous proteolytic cleaved form of the a-ENaC protein (29) . Furthermore, a neutralizing peptide was used to confirm a-ENaC antibody specificity ( Figure E2, lane  3) . The signal of the 65-kD band detected in lanes 1 and 2 was abolished by the neutralizing peptide (lane 3).
In addition, we performed immunofluorescence experiments to detect d-ENaC exclusively at the cell surface with the specific anti-ENaC antibodies, which bind to the extracellular loop. For this approach we used QD-labeled anti-rabbit F(ab9)2 conjugates as secondary antibodies. Experiments were performed with material from five different patients and at least 30 cells were analyzed. Using this technique we were able to show that the d-subunit is expressed at the cell surface and/or in nearby regions. Using this method, we compared the expression of d-ENaC with the classically expressed a-subunit and quantified ENaC molecules at the cell surface. Representative images for both subunits are shown in Figures 3A and 3B . We counted the abundance of QD-labeled ENaC molecules/mm 2 apical cell surface of HNE for each cell, thereby demonstrating that the amount of a-ENaC molecules is only slightly larger (0. (Figure 3C ), suggesting that in HNE both subunits are expressed in a similar manner.
Transepithelial Measurements
The electrophysiologic parameters in HNE were determined in modified Ussing chambers. We used amiloride (100 mM) to identify total ENaC current. Subsequent application of the d-ENaC subunit specific blocker Evans Blue (300 mM) revealed the portion of transepithelial current mediated by the d-subunit. Figure 4A shows the I sc of cultured monolayers from HNE. I sc is markedly inhibited by amiloride, demonstrating the Na 1 absorption via ENaC, which represents 39.1 6 2.3% of total Na 1 absorption, determined by removing Na 1 from the apical Ringer. In a second step the effects of Evans Blue in the absence and presence of amiloride are shown. When Evans Blue was applied to the apical side, the Na 1 absorption was inhibited by 19.8 6 1.9% on average. The simultaneous application of amiloride and Evans Blue led to a decrease of the transepithelial Na 1 absorption by 40.1 6 2.2% ( Figure 4B) . Thus, the portion of Evans Bluesensitive current dependent on the amiloride-sensitive Na 1 current is approximately 50%. To verify the specificity of Evans Blue and the contribution of d-ENaC to native Na 1 transport across epithelia, we down-regulated d-ENaC expression with siRNA complementary to this subunit.
In these functional transfection analyses we could demonstrate that the application of amiloride only slightly inhibited the transepithelial Na 1 absorption compared with the untransfected monolayers, thereby representing the remaining a-ENaC current ( Figure 5A ). As expected, the addition of Evans Blue revealed only a marginal change of the I sc , dependent on the down-regulation of d-ENaC. Thereby, we could show that after 24 hours the Evans Blue-sensitive current was reduced from 19.8% to 0.7% ( Figure 5B ) and therefore almost completely abolished (reduction: 96.7%). Thus, we can assume that Evans Blue is also in native tissue d-ENaC specific, and it is possible to determine its contribution to the native Na 1 transport of human primary cultured cells.
DISCUSSION
The detection of the d-ENaC subunit in HNE alters the point of view on ENaC function. In previous studies we demonstrated that a-, b-, and g-ENaC are expressed in this tissue (21) . Here we show that the d-ENaC subunit also is constitutively expressed in respiratory epithelia. Co-expression of these subunits was reported previously for cell cultures of human lung origin (H441 and A549) (14) , human epidermis, and keratinocytes (15) . But no functional proof for d-ENaC expression was found in native tissue yet. In a first approach we cloned and sequenced the cDNA of the d-subunit and could show that at least isoform 1 is expressed in HNE. This verification was followed by the detection of the d-ENaC protein using Western blot analyses. Thus, we could show that the d-subunit is present in the total membrane protein extract of human nasal cells. By using immunofluorescence experiments we compared the expression of the d-subunit with the classically expressed a-subunit at the apical cell surface and showed that the quantity of both subunits is almost similar. These results revealed that the amount of a-ENaC molecules is only slightly higher than that of d-ENaC molecules, suggesting that in HNE both subunits are expressed in a similar manner. This observation indicates that the d-ENaC subunit plays an important role in Na 1 transport in respiratory epithelia.
To obtain functional data of the d-subunit in the apical membrane of HNE we performed electrophysiologic tests using Ussing chamber measurements. Previously, it was shown that amiloride is a well-known blocker of both channel complexes (abg, dbg), while Evans Blue inhibits the d-subunit current specifically, but does not affect the a-subunit current (24) . With the transepithelial measurements we observed an Evans Bluesensitive current that was clearly distinguishable from the amiloride-sensitive current by using Evans Blue alone in comparison to an amiloride/Evans Blue mixture. The portion of the d-ENaC-mediated Na 1 current was 19.8 6 1.9% in average of total ENaC current. When both blockers were applied, 40.1 6 2.2% of ENaC current was inhibited. Thus, the Evans Blue-sensitive Na 1 current contributes approximately 50% to the amiloride-sensitive current. To prove that the Evans Blue-sensitive Na 1 current is indeed mediated by the d-subunit, we down-regulated the expression of d-ENaC in primary cultures of HNE with d-ENaC-specific siRNA. We showed by semiquantitative RT-PCR and Western blot analyses an effective knockdown of d-ENaC expression. Furthermore, the Western blot reveals that the expression of the a-subunit remains unaffected ( Figure E2 ). Subsequently, we demonstrated this down-regulation in Ussing chamber experiments, thereby demonstrating that the Evans Blue-sensitive current is nearly completely reduced after 24 hours (96.7%). Although several studies revealed that Evans Blue is able to modulate receptors and ion channels (30-33), we could not observe any effect on other anion channels in our cell preparations, verified by the addition of Na 1 -free Ringer solution in combination with Evans Blue in Ussing chamber experiments (data not shown). The high specificity of such siRNA molecules prompted us to assume that Evans Blue is d-ENaC specific in native tissue and it is possible to determine its contribution to the native Na 1 transport of human primary cultured cells.
Up to now the physiologic and pathologic role of d-ENaC in nonneuronal tissues is still unclear, but our findings raise the question of whether the d-ENaC subunit possesses important regulatory functions and whether it interacts with other ENaC subunits or members of the DEG/ENaC family in the human respiratory epithelium. Former in vitro studies of other groups showed that the d-subunit leads to differentiated biophysical and pharmacologic ENaC properties that could modify functional properties of the channel (14) . They demonstrated that the selectivity for monovalent and divalent cations, single channel conductance, amiloride affinity, gating kinetics, and proton activation of abgd-ENaC were different from those of abg-and dbg-ENaC. Furthermore, Yamamura and coworkers demonstrated that homomeric d-ENaC is sensitive for protons (13) , and Ji and Benos showed the same for the dbg complex (34) . In addition, it is known that ENaC subunit expression as well as regulation is tissue specific. It was shown that several cells in the lung express only the a-and g-ENaC subunits (35) , while in colon and kidney ENaC expression is extremely dependent on aldosterone stimulation (12, 36) . Thus, a tissue-specific subunit composition with modified ENaC properties of the channel is likely. The modulated subunit formation of ENaC could enable epithelial cells to respond to different extracellular parameters by an altered subunit expression and stoichiometry. Thus, it could be possible that these combinations lead to different biophysical and also pharmacologic features of the channel. These are certainly speculative presumptions, and there is no evidence of this modulation in vivo yet. A variety of studies showed that culture conditions, cellular protein polarization, subunit composition, and splice variants also can be responsible for the diversity in channel properties (37) (38) (39) .
In conclusion, we found that the d-ENaC mRNA and protein are expressed in HNE, and functional measurements support the presumption that this subunit plays a prominent part in the whole Na 1 transport in this particular tissue. The observance of a-, b-, g-and d-ENaC co-expression in HNE provides an insight in variability of ENaC expression and distribution that enlarges the possibilities of regulation and channel properties in respiratory epithelia. Our data confirm and extend the existing knowledge with regard to ENaC distribution and function. This offers new perceptions to the complex and tissue specific appearance of the large variety of epithelial sodium channels.
